+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial



Safe use of ursodeoxycholic acid in the treatment of dyspeptic symptoms in patients with chronic active hepatitis: a double-blind controlled trial



Journal of International Medical Research 10(4): 278-282




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 044265410

Download citation: RISBibTeXText

PMID: 7117685

DOI: 10.1177/030006058201000416


Related references

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind placebo-controlled trial. Journal of Hepatology 20(3): 315-320, 1994

Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. European Journal of Clinical Pharmacology 40(5): 473-476, 1991

One year ursodeoxycholic acid treatment of chronic viral hepatitis in heart transplanted patients Results of a prospective double-blind placebo randomized controlled study in 60 patients. Journal of Hepatology 25(SUPPL 1): 127, 1996

A multicenter, double-blind, controlled study comparing taurohyodeoxycholic vs ursodeoxycholic acid in gallstone and dyspeptic patients. Gastroenterology 112(4 SUPPL ): A1212, 1997

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Gut 56(12): 1747-1753, 2007

Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial. Journal of the American College of Cardiology 59(6): 585-592, 2012

Ursodeoxycholic acid udca in chronic hepatitis a double blind multicenter clinical trial. Gastroenterology 100(5 PART 2): 719, 1991

Double blind controlled trial of ursodeoxycholic acid udca versus placebo in the treatment of reflux gastritis in patients not submitted to gastric surgery. Acta Endoscopica 19(4): 251-257, 259-260, 1989

Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: A double-blind, placebo-controlled trial on symptomatic patients. Alimentary Pharmacology & Therapeutics 15(9): 1427-1434, September, 2001

Gallbladder hypokinesia and normal gastric emptying of liquids in patients with dyspeptic symptoms a double blind placebo controlled trial with cisapride. Gastroenterology 98(5 PART 2): A255, 1990

Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial. Journal of Hepatology 8(1): 7-12, 1989

Gallbladder hypokinesia and normal gastric emptying of liquids in patients with dyspeptic symptoms. A double-blind placebo-controlled clinical trial with cisapride. Digestive Diseases and Sciences 37(2): 262-267, 1992

Treatment of chronic viral C hepatitis by interferon plus ursodeoxycholic acid Results from a controlled randomized trial in 80 patients. Hepatology 20(4 PART 2): 169A, 1994